DLL3-CD3 BISPECIFIC ANTIBODIES
Brazil Patent
Stats

Importance

BR Family Size
|
Non-US Coverage
|
Abstract
anticorpos biespecíficos dll3-cd3. a presente invenção refere-se a novas proteínas de ligação à dll3/cd3. a invenção também se refere a ácidos nucleicos que codificam tais proteínas; a métodos para preparar tais proteínas; a células hospedeiras que expressam ou são capazes de expressar tais proteínas; a composições que compreendem tais proteínas; e aos usos de tais proteínas ou composições, em particular para fins terapêuticos no campo de doenças cancerosas.

First Claim
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Country Designations

Patent Owner(s)
Patent Owner | Address |
---|---|
BOEHRINGER INGELHEIM INT | DEBINGER STRASSE 173 55216 INGELHEIM AM RHEIN DE |
International Classification(s)

- [Classification Symbol]
- [Patents Count]
Inventor(s)
Inventor Name | Address |
---|---|
SUSANNE HIPP | DE |
PAUL ADAM | 55216 INGELHEIM AM RHEIN BOEHRINGER INGELHEIM INTERNATIONAL GMBH CORPORATE PATENTS BINGER STRASSE 173 |
RAJKUMAR GANESAN | THOUSAND OAKS VENTURA COUNTY CALIFORNIA |
JUSTIN SCHEER | CALIFORNIA 1 DNA WAY SOUTH SAN FRANCISCO |
PANKAJ GUPTA | RIDGEFIELD CONNECTICUT 06877-0368 C/O VP IP LEGAL BOEHRINGER INGELHEIM USA CORPORATION 900 RIDGEBURY ROAD P O BOX 368 |
MICHAEL DZIEGELEWSKI | IP LEGAL BOEHRINGER INGELHEIM USA CORP 900 RIDGEBURY ROAD P O BOX 368 RIDGEFIELD |
PRIYANKA GUPTA | CONNECTICUT 06877-0368 C/O VP IP LEGAL BOEHRINGER INGELHEIM USA CORP 900 RIDGEBURY RD P O BOX 368 RIDGEFIELD |
PHILIP NICHOLAS GORMAN | US |
VLADIMIR H VOYNOV | US |
Cited Art Landscape
- No Cited Art to Display

Full Text

Legal Events

Matter Detail

Renewals Detail

Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:

Add to additional portfolios:

Note
The template below is formatted to ensure compatibility with our system.
Provide tags with | separated like (tags1|tags2).
Maximum length is 128 characters for Customer Application No
Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.
Acceptable Date Format - 'MM/DD/YYYY'.
Acceptable Filing/App Types -
- Continuation/Divisional
- Original
- Paris Convention
- PCT National
- With Priority
- EP Validation
- Provisional Conversion
- Reissue
- Provisional
- Foreign Extension
Acceptable Status -
- Pending
- Abandoned
- Unfiled
- Expired
- Granted
Acceptable Matter Types -
- Patent
- Utility Model
- Supplemental Protection Certificate
- Design
- Inventor Certificate
- Plant
- Statutory Invention Reg
Advertisement
Advertisement
Advertisement

Recipient Email Address

Recipient Email Address

Comment
Recipient Email Address

Success
E-mail has been sent successfully.
Failure
Some error occured while sending email. Please check e-mail and try again!
Important Notes on Latency of Status data
This Status indicator is an estimation based on the relevant document kind code. As such, it status will only indicate "Published" or "Granted". Expired, lapsed or abandoned statuses are not available in this release. Please refer to the legal status information for more information.
This status should not be taken as legal conclusion. No representations are made as to the accuracy of the status provided. Please consult a legal professional before relying on this status information.
Important Note on Priority Date data
This priority date is an estimated earliest priority date and is purely an estimation. This date should not be taken as legal conclusion. No representations are made as to the accuracy of the date listed. Please consult a legal professional before relying on this date.
Only for Granted EP cases
EP validations represent the countries in which the EP patent may be in force. Data is based on reporting from the various EP contracting states. The reporting consistency can vary across the countries.